Maxcyte (MXCT) Inventory Average (2021 - 2026)

Maxcyte (MXCT) has 6 years of Inventory Average data on file, last reported at $7.6 million in Q1 2026.

• Quarterly Inventory Average fell 11.69% year-over-year to $7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.6 million (down 11.69% YoY) and the FY2025 annual result came in at $8.2 million, down 22.14% from the prior year.
• Inventory Average steadied at $7.6 million in Q1 2026 per MXCT's latest filing, from $7.6 million in the prior quarter.
• Across five years, Inventory Average topped out at $12.4 million in Q4 2023 and bottomed at $5.9 million in Q1 2022.
• The 5-year median for Inventory Average is $8.6 million (2025), against an average of $9.2 million.
• The widest annual swing landed in 2022, when Inventory Average jumped 87.95%; it then fell 29.9% in 2025.
• Tracing MXCT's Inventory Average over 5 years: stood at $8.2 million in 2022, then surged by 50.14% to $12.4 million in 2023, then slipped by 22.03% to $9.7 million in 2024, then declined by 21.49% to $7.6 million in 2025, then increased by 0.13% to $7.6 million in 2026.
• Per Business Quant, the three latest MXCT Inventory Average figures stand at $7.6 million (Q1 2026), $7.6 million (Q4 2025), and $7.8 million (Q3 2025).

Peer Comparison